Therefore, it is conceivable that when the levels of inflammatory factors are elevated in T2DM, PTPN2 expression is downregulated in immunocytes but upregulated in epithelial cells (as seen in other studies) and acts synergistically with VDR to attenuate the inflammation and protect against renal injury. This evidence concerns the gene PTPN2 and type 2 diabetes mellitus.